Interferon-␥ (IFN-␥
IFN-␥1 is a bilaterally symmetric noncovalent dimer that binds two primary ligand-binding receptor chains (IFN-␥R1) in structurally equivalent positions (1, 2). We define IFN-␥ as a divalent ligand because of this property. According to the current model of IFN-␥ signal transduction, after ligand binding and receptor complex activation (Fig. 1), the IFN-␥ receptor complex is composed of one IFN-␥ dimer, two IFN-␥R1 chains, two IFN-␥R2 chains, two Jak1 molecules, and two Jak2 molecules (3-8). In this report, we address whether both halves of the receptor complex must be activated for signaling and whether a functional signaling receptor complex can be formed with only two receptor chains (one IFN-␥R1 and one IFN-␥R2 chain) instead of four chains. In order to address these questions, we designed and assayed a dimeric IFN-␥ molecule that can bind only one ligand binding receptor chain (a monovalent IFN-␥).A tandem covalently linked dimer of IFN-␥ (9), designated ␥-␥, is an ideal ligand for studying the importance of ligand divalency for receptor activation because one of two receptor binding sites can be selectively eliminated to create a monovalent IFN-␥. The ␥-␥ was synthesized by linking two DNA sequences encoding monomers of wild type IFN-␥, a noncovalent IFN-␥ dimer designated ␥⅐␥, with DNA encoding a linker region from the IgA 1 molecule (9). This ␥-␥ had similar chromatographic properties as ␥⅐␥ and was conformationally similar to ␥⅐␥ as judged by 1 H NMR (9). In binding competition studies, ␥-␥ effectively competed with radiolabeled ␥⅐␥ for receptors on U937 cells, and its specific antiviral activity was 50 -65% that of ␥⅐␥ (9). With the two IFN-␥ monomers of ␥-␥ fused, it was possible to mutate each monomer segment separately to eliminate either one of the two receptor binding sites of ␥-␥. It was previously demonstrated that mutagenesis of residues 20 -25 of ␥⅐␥ within the AB loop (1, 2) dramatically reduced the ability of ␥⅐␥ to bind to its receptor as judged by competition studies on U937 cells (10). These residues of the AB loop are part of a 3 10 helix that contacts IFN-␥R1 directly (2). The 1 H NMR spectrum of one such mutant, IFN-␥/A23E,D24E,N25K (IFN-␥/EEK; also designated ␥ m ⅐ ␥ m ), was nearly identical to that of ␥⅐␥, demonstrating that its overall structure is retained; however, it possessed less than 0.01% of the ability of ␥⅐␥ to compete for receptor binding to U937 cells (10). Consistent with its weak binding, this mutant possessed undetectable antiviral activity and stimulated HLA-DR␣ promoter activity only at over 100 nM protein (10). Thus, this mutation effectively eliminates the ability of IFN-␥ to bind to and activate its cellular receptor. Accordingly, we targeted these residues to inactivate each of the two receptor binding sites of ␥-␥ to create two monovalent ␥-␥ molecules. This report describes how these monovalent mutants of ␥-␥ were used to show that interaction of IFN-␥ with one-half of the receptor complex is sufficient to initiate signal transduction.